Advanced or metastatic ovarian cancer, NSCLC, pancreatic cancer, and other mesothelin expressing cancers research hub

A Study of ZW171 in Participants with Advanced or Metastatic Mesothelin Expressing Cancers

This study is testing a new medicine, ZW171, for people with advanced or spreading cancers like ovarian, lung (NSCLC), and pancreatic cancer that have a specific protein called mesothelin. It's an early-stage study to see how safe the medicine is and if it works.